Candel Therapeutics (CADL) Current Leases (2022 - 2025)
Candel Therapeutics (CADL) reported Current Leases of $445000.0 for Q4 2025, down 21.38% on a YoY basis from $566000.0 in Q4 2024, and up 1.83% sequentially from $437000.0 in Q3 2025.
Candel Therapeutics (CADL) Current Leases (2022 - 2025) Analysis & Trends
Candel Therapeutics (CADL) has 4 years of Current Leases data on file, last reported at $445000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Leases fell 21.38% year-over-year to $445000.0; the trailing twelve-month figure through Dec 2025 stood at $445000.0 (down 21.38% YoY), and the FY2025 full-year result was $445000.0, down 21.38% from the prior year.
- Current Leases climbed to $445000.0 in Q4 2025, from $437000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $594000.0 in Q2 2025 to a low of $429000.0 in Q1 2022.
- A 4-year average of $500062.5 and a median of $494000.0 in 2023 frame the typical range for Current Leases.
- Across the five-year window, Current Leases climbed 10.96% in 2023 and slipped 21.38% in 2025, its largest moves.
- Tracing CADL's Current Leases over 4 years: stood at $464000.0 in 2022, then advanced by 10.56% to $513000.0 in 2023, then grew by 10.33% to $566000.0 in 2024, then retreated by 21.38% to $445000.0 in 2025.
- Business Quant data shows CADL's Current Leases at $445000.0 in Q4 2025, $437000.0 in Q3 2025, and $594000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - | 445,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 445,000.00 |
| Sep 30, 2025 | 437,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Mar 31, 2025 | 580,000.00 |
| Dec 31, 2024 | 566,000.00 |
| Sep 30, 2024 | 552,000.00 |
| Jun 30, 2024 | 539,000.00 |
| Mar 31, 2024 | 526,000.00 |
| Dec 31, 2023 | 513,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 488,000.00 |
| Mar 31, 2023 | 476,000.00 |
| Dec 31, 2022 | 464,000.00 |
| Sep 30, 2022 | 452,000.00 |
| Jun 30, 2022 | 440,000.00 |
| Mar 31, 2022 | 429,000.00 |